Tenon Medical Inc Cash Flow Conversion Efficiency
Tenon Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Tenon Medical Inc (TNON) has a cash flow conversion efficiency ratio of 1.582x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.76 Million) by net assets ($-1.74 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Tenon Medical Inc (2019–2025)
Cash flow conversion efficiency of Tenon Medical Inc from 2019 to 2025. This chart illustrates how Tenon Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Tenon Medical Inc for real-time trading data and today's change.
Tenon Medical Inc Cash Flow Conversion Ratio Explained
Tenon Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Tenon Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tenon Medical Inc ranked by their cash flow conversion efficiency. Also see market value of Tenon Medical Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Instinct Bio Technical Company Holdings Inc. Ordinary Shares
NASDAQ:BIOT
|
N/A |
|
Stuhini Exploration Ltd
V:STU
|
-0.019x |
|
Me Group International PLC
LSE:MEGP
|
0.180x |
|
Land & Homes Group Ltd
AU:LHM
|
0.720x |
|
Tinybeans Group Ltd
AU:TNY
|
-0.191x |
|
Twin Vee Powercats Co
NASDAQ:VEEE
|
-0.112x |
|
Nippon Active Value Fund Plc
LSE:NAVF
|
0.005x |
|
Top KingWin Ltd
NASDAQ:WAI
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Tenon Medical Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Tenon Medical Inc from 2019 to 2025. Review TNON FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $5.04 Million | $-10.74 Million | -2.132x | -28.87% |
| 2024-12-31 | $5.97 Million | $-9.88 Million | -1.654x | +89.44% |
| 2023-12-31 | $778.00K | $-12.18 Million | -15.659x | -714.16% |
| 2022-12-31 | $6.25 Million | $-12.03 Million | -1.923x | -1021.00% |
| 2021-12-31 | $-20.55 Million | $-4.29 Million | 0.209x | +79.30% |
| 2020-12-31 | $-1.44 Million | $-167.36K | 0.116x | -20.07% |
| 2019-12-31 | $-1.61 Million | $-235.20K | 0.146x | -- |
About Tenon Medical Inc
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It als… Read more